149 related articles for article (PubMed ID: 21486527)
1. Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route.
Mishra H; Mishra D; Mishra PK; Nahar M; Dubey V; Jain NK
J Pharm Pharm Sci; 2010; 13(4):495-509. PubMed ID: 21486527
[TBL] [Abstract][Full Text] [Related]
2. Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.
Sahu KK; Pandey RS
Int Immunopharmacol; 2016 Oct; 39():343-352. PubMed ID: 27526270
[TBL] [Abstract][Full Text] [Related]
3. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers.
Dewangan HK; Pandey T; Maurya L; Singh S
Int J Biol Macromol; 2018 May; 111():804-812. PubMed ID: 29343454
[TBL] [Abstract][Full Text] [Related]
4. HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay.
Rezaei M; Hosseini SN; Khavari-Nejad RA; Najafi F; Mahdavi M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1543-1558. PubMed ID: 31007088
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system.
Jain V; Sahu R; Misra-Bhattacharya S; Vyas SP; Kohli D
J Drug Target; 2008 Nov; 16(9):706-15. PubMed ID: 18982519
[TBL] [Abstract][Full Text] [Related]
6. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
[TBL] [Abstract][Full Text] [Related]
8. Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid PLA Microparticles with Adsorbed Hepatitis B Surface Antigen.
Liu Q; Chen X; Jia J; Lu T; Yang T; Wang L
Mol Pharm; 2018 Nov; 15(11):5227-5235. PubMed ID: 30350642
[TBL] [Abstract][Full Text] [Related]
9. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
Saini V; Jain V; Sudheesh MS; Dixit S; Gaur RL; Sahoo MK; Joseph SK; Verma SK; Jaganathan KS; Murthy PK; Kohli D
J Drug Target; 2010 Apr; 18(3):212-22. PubMed ID: 19883203
[TBL] [Abstract][Full Text] [Related]
11. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
Wang H; Han Q; Zhao H; Xu D; Zhang J
Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
[TBL] [Abstract][Full Text] [Related]
12. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
Jain S; Singh P; Mishra V; Vyas SP
Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
[TBL] [Abstract][Full Text] [Related]
13. APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine.
Layek B; Lipp L; Singh J
J Control Release; 2015 Jun; 207():143-53. PubMed ID: 25886704
[TBL] [Abstract][Full Text] [Related]
14. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
15. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
[TBL] [Abstract][Full Text] [Related]
16. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
Shukla A; Katare OP; Singh B; Vyas SP
Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
[TBL] [Abstract][Full Text] [Related]
17. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
Schirmbeck R; Reimann J
Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
[TBL] [Abstract][Full Text] [Related]
18. Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis.
Zhu J; Qin F; Ji Z; Fei W; Tan Z; Hu Y; Zheng C
AAPS PharmSciTech; 2019 Dec; 21(1):13. PubMed ID: 31807947
[TBL] [Abstract][Full Text] [Related]
19. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
